Physician profile
Mark N Perlmutter
NPI 1467540534
$5,806.55
in general payments reported to CMS, 2019-2025
25 companies · $168 in 2025
The $168 reported for 2025 was less than what a typical Hand Surgery provider received nationally (typical 2025 total: $270).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $139 · 2020: $1,379 · 2021: $3,812 · 2022: $196 · 2023: $60.40 · 2024: $53.60 · 2025: $168.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $282.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $281.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $3,352.78 | 2020-2021 | |
| Southtech Orthopedics | $1,502.33 | 2020-2021 | |
| Nevro Corp. | $144.09 | 2020-2024 | Senza |
| Ibsa Pharma INC. | $139.82 | 2022-2023 | Tirosint, Licart |
| Collegium Pharmaceutical, INC. | $97.44 | 2021-2025 | Belbuca |
| Scilex Pharmaceuticals INC. | $75.47 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $64.69 | 2019-2022 | |
| Radius Health, INC. | $41.72 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $40.33 | 2019 | |
| Kerecis Limited | $39.62 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Globus Medical, INC. | $35.17 | 2025 | Anthem, Autobahn, Senza |
| Depuy Synthes Sales INC. | $30.06 | 2022 | |
| Ferring Pharmaceuticals INC. | $28.73 | 2025 | Adstiladrin |
| Sanofi-Aventis U.S. LLC | $24.58 | 2019-2020 | |
| Musculoskeletal Transplant Foundation INC. | $23.99 | 2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $22.49 | 2021 | |
| Vertex Pharmaceuticals Incorporated | $21.08 | 2025 | |
| Integra Lifesciences Corporation | $19.29 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Smith+Nephew, INC. | $17.39 | 2020 | |
| Bioventus LLC | $17.18 | 2025 | Xcell |
| Redhill Biopharma INC. | $16.44 | 2021 | |
| Arbor Pharmaceuticals, INC. | $15.22 | 2021 | |
| Daiichi Sankyo INC. | $14.67 | 2019 | |
| Biodelivery Sciences International, INC. | $13.11 | 2021 | |
| Heraeus Medical, LLC. | $8.86 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Perlmutter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.